Affinity Technologies shares 3 new case studies in which CyPath Lung detected Stage 1A lung cancer or prevented unnecessary ...
A cutting-edge bronchoscope that is guided with the help of a robot can reach very small tumors growing in hard-to-reach ...
An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer ...
Healthway Cancer Care Hospital (HCCH), the country’s first specialized hospital for cancer treatment, has teamed up with ...
Incidental pulmonary nodules are a common finding on chest imaging, but one program is taking an uncommon approach to managing them. Incidental nodules present a growing diagnostic and management ...
bioAffinity Technologies’ noninvasive diagnostic shifted the course of care from watchful waiting for up to 5 years to confirmed malignancy and immediate treatment SAN ANTONIO, September 09, ...
ABSTRACT: Background: The increasing use of diagnostic imaging, particularly low-dose CT (LDCT) for lung cancer screening, has led to an increase in the detection of solitary pulmonary nodules. While ...
ABSTRACT: Background: The increasing use of diagnostic imaging, particularly low-dose CT (LDCT) for lung cancer screening, has led to an increase in the detection of solitary pulmonary nodules. While ...
Traverse City, Mich.-based Munson Medical Center has completed its first lung cancer procedure performed entirely under a single anesthetic event, according to a July 29 report from The Traverse ...
Meningioma is a common tumor of the central nervous system, with occasional occurrences outside this region. Herein, we present a case of primary pulmonary meningioma (PPM) in a 64-year-old male who ...
Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient with Inconclusive Imaging
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW),a biotechnology company addressingthe need for noninvasive, accurate tests for the detection of early-stage cancer, today released a new case study ...
Despite the rising incidence of rheumatoid arthritis (RA), extra-articular manifestations have become rare in the era of modern treat-to-target therapy. However, they still present clinical challenges ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback